
    
      This is an open-label, prospective, 1:1 randomized, parallel-group, study to evaluate the
      efficacy of expanded hemodialysis (HDx) compared to conventional hemodialysis in patients
      with chronic kidney disease in South Korea for up to 12 months.
    
  